CA21140 “Interception of oral cancer development” (INTERCEPTOR)

Datos básicos

Código:

EU23/03

Dotación:

Año Inicial:

2023

Año final:

2026

Objetivos del proyecto

The INTERCEPT COST Action addresses the challenge of unmet oral cancer prevention and bring new paradigm to disease management of oral potentially malignant disorders (OPMD). Relying on excellent translational research, patient care and education in Europe (EU) in the field of cancer medicine, INTERCEPT will develop future strategies of personalized OPMD preventive and care approaches. Pluridisciplinary expertise will involve and target a spectrum of keys actors to ensure a long-term success.

Unidades de investigación

• NANOMEDICINA

  

  Investigador Responsable

  Mónica López Fanarraga

  monica.lopez@unican.es